{"id":{"repo_id":"london-metro","oai_identifier":"oai:repository.londonmet.ac.uk:7519"},"canonical_url":"https://search.dev.ndltd.org/etd/london-metro/oai:repository.londonmet.ac.uk:7519","repository":{"repo_id":"london-metro","name":"London Metropolitan University","base_url":"https://repository.londonmet.ac.uk/cgi/oai2"},"display":{"title":"Legal aspects of trade in medicines","abstract":"This thesis considers from a comparative legal basis the existing controls upon the supply of medicines throughout the world. It assesses the desirability and effectiveness of those controls and makes recommendations as to how these could be improved. Part I describes and analyses the legislative controls over medicines as contained in the United Kingdom Medicines Act 1968. In particular there is discussion of licensing systems, the role of the prescribing doctor and aspects of consumer safety. Part II considers the effect upon the United Kingdom of entry in to the European Economic Community in relation to trade in medicines. Free movement of goods, competition policy and harmonisation of the legislation of Member States are the main themes discussed. Part III deals with trade in medicines in relation to the Third World. The external relations policy of the EEC is discussed and its interaction with GATT. Also considered are the roles played by the various agencies of the United Nations in relation to the supply of medicines and the activities of transnational pharmaceutical companies in this field. Part IV is concerned with some specific problems posed by trade in medicines, including consumer safety, product liability, price control and post-marketing surveillance. Part V deals with the development of the supply of medicines as a human right and the part played by non-government organisations in securing that aim upon a global basis. Part VI contains conclusions and recommendations, in which the role of the World Health Organisation is discussed in relation to a new pharmaceutical code of conduct.","abstract_html":"This thesis considers from a comparative legal basis the existing controls upon the supply of medicines throughout the world. It assesses the desirability and effectiveness of those controls and makes recommendations as to how these could be improved. Part I describes and analyses the legislative controls over medicines as contained in the United Kingdom Medicines Act 1968. In particular there is discussion of licensing systems, the role of the prescribing doctor and aspects of consumer safety. Part II considers the effect upon the United Kingdom of entry in to the European Economic Community in relation to trade in medicines. Free movement of goods, competition policy and harmonisation of the legislation of Member States are the main themes discussed. Part III deals with trade in medicines in relation to the Third World. The external relations policy of the EEC is discussed and its interaction with GATT. Also considered are the roles played by the various agencies of the United Nations in relation to the supply of medicines and the activities of transnational pharmaceutical companies in this field. Part IV is concerned with some specific problems posed by trade in medicines, including consumer safety, product liability, price control and post-marketing surveillance. Part V deals with the development of the supply of medicines as a human right and the part played by non-government organisations in securing that aim upon a global basis. Part VI contains conclusions and recommendations, in which the role of the World Health Organisation is discussed in relation to a new pharmaceutical code of conduct.","abstract_has_math":false,"creators":["Parke, Michael Ronald"],"institution":"City of London Polytechnic","degree_name":"phd","degree_level":"doctoral","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":1989,"date_issued":"1989-03","date_published":"1989-03","updated_at":"2026-07-24T02:54:41Z","subjects":["340 Law"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.grantnumber","label":"Dc Identifier Grantnumber","values":["N/A"],"render_values":[{"text":"N/A","href":null,"code":true}]}]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["London Metropolitan University"]},{"key":"dc:creator","label":"Author","values":["Parke, Michael Ronald"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["1989-03"]},{"key":"dc:date.issued","label":"Date","values":["1989-03"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["Guildhall School of Business and Law (GSBL)","Guildhall School of Business and Law"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["City of London Polytechnic"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://repository.londonmet.ac.uk/7519/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["doctoral"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["phd"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["340 Law"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.grantnumber","label":"Dc Identifier Grantnumber","values":["N/A"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://repository.londonmet.ac.uk/7519/1/253785.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["This thesis considers from a comparative legal basis the existing controls upon the supply of medicines throughout the world. It assesses the desirability and effectiveness of those controls and makes recommendations as to how these could be improved. Part I describes and analyses the legislative controls over medicines as contained in the United Kingdom Medicines Act 1968. In particular there is discussion of licensing systems, the role of the prescribing doctor and aspects of consumer safety. Part II considers the effect upon the United Kingdom of entry in to the European Economic Community in relation to trade in medicines. Free movement of goods, competition policy and harmonisation of the legislation of Member States are the main themes discussed. Part III deals with trade in medicines in relation to the Third World. The external relations policy of the EEC is discussed and its interaction with GATT. Also considered are the roles played by the various agencies of the United Nations in relation to the supply of medicines and the activities of transnational pharmaceutical companies in this field. Part IV is concerned with some specific problems posed by trade in medicines, including consumer safety, product liability, price control and post-marketing surveillance. Part V deals with the development of the supply of medicines as a human right and the part played by non-government organisations in securing that aim upon a global basis. Part VI contains conclusions and recommendations, in which the role of the World Health Organisation is discussed in relation to a new pharmaceutical code of conduct."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dc:title","label":"Title","values":["Legal aspects of trade in medicines"]}]}],"canonical_facts":{"dc:contributor.sponsor":["London Metropolitan University"],"dc:creator":["Parke, Michael Ronald"],"dc:date":["1989-03"],"dc:date.issued":["1989-03"],"dc:description.abstract":["This thesis considers from a comparative legal basis the existing controls upon the supply of medicines throughout the world. It assesses the desirability and effectiveness of those controls and makes recommendations as to how these could be improved. Part I describes and analyses the legislative controls over medicines as contained in the United Kingdom Medicines Act 1968. In particular there is discussion of licensing systems, the role of the prescribing doctor and aspects of consumer safety. Part II considers the effect upon the United Kingdom of entry in to the European Economic Community in relation to trade in medicines. Free movement of goods, competition policy and harmonisation of the legislation of Member States are the main themes discussed. Part III deals with trade in medicines in relation to the Third World. The external relations policy of the EEC is discussed and its interaction with GATT. Also considered are the roles played by the various agencies of the United Nations in relation to the supply of medicines and the activities of transnational pharmaceutical companies in this field. Part IV is concerned with some specific problems posed by trade in medicines, including consumer safety, product liability, price control and post-marketing surveillance. Part V deals with the development of the supply of medicines as a human right and the part played by non-government organisations in securing that aim upon a global basis. Part VI contains conclusions and recommendations, in which the role of the World Health Organisation is discussed in relation to a new pharmaceutical code of conduct."],"dc:format":["text"],"dc:identifier.grantnumber":["N/A"],"dc:identifier.uri":["https://repository.londonmet.ac.uk/7519/1/253785.pdf"],"dc:publisher.department":["Guildhall School of Business and Law (GSBL)","Guildhall School of Business and Law"],"dc:publisher.institution":["City of London Polytechnic"],"dc:relation.isreferencedby":["https://repository.londonmet.ac.uk/7519/"],"dc:subject":["340 Law"],"dc:title":["Legal aspects of trade in medicines"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["doctoral"],"dc:type.qualificationname":["phd"]},"updated_at":"2026-07-24T02:54:41Z"}